Patient Preferences in Pulmonary Arterial Hypertension, a Latent Class Analysis to Identify Preference Heterogeneity

被引:0
|
作者
Muehlbacher, Axel [1 ,2 ,5 ,6 ]
Beaudet, Amelle [3 ]
Brand, Monika [3 ]
Janssen, Ellen M. [4 ]
Gunz, Holger [4 ]
Li, Wenjing [3 ]
Preiss, Michael [3 ]
Sadler, Andrew [2 ]
Disantostefano, Rachael L. [4 ]
机构
[1] Hsch Neubrandenburg, Hlth Econ & Hlth Care Management, Neubrandenburg, Germany
[2] Gesell Empir Beratung GmbH, Berlin, Germany
[3] Janssen Pharmaceut Co Johnson & Johnson, Actelion Pharmaceut Ltd, Allschwil, Switzerland
[4] Janssen Cilag Germany, Johnson & Johnson Pl, Neuss, North Rhine Wes, Germany
[5] Janssen Res & Dev LLC, Global Epidemiol, Titusville, NJ USA
[6] Gesell Empir Beratung GmbH, Hans Otto Str 30, D-10407 Berlin, Germany
关键词
best-worst scaling; latent class analysis; patient preferences; pulmonary arterial hypertension; DISCRETE-CHOICE EXPERIMENTS; CONJOINT-ANALYSIS APPLICATIONS; HEALTH; MODEL;
D O I
10.1016/j.jval.2023.10.012
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: Pulmonary arterial hypertension (PAH) is a chronic, progressive disease of the pulmonary circulation characterized by vascular remodeling that, if untreated, can lead to right heart dysfunction and death. This analysis measured heterogeneity in patient preferences for PAH-specific treatment regimens. Method: Adult patients with PAH with slight to marked limitations during physical activity were recruited through a patient organization in Germany. Participants completed an online best-worst scaling case 3 survey. Patients chose among 3 hypothetical treatment profiles defined by 6 benefits and risks at varying levels. Participants completed 12 choice tasks. Preference heterogeneity was assessed using latent class analysis. Results: A total of 83 participants (76% female) completed the survey. Best-fit model revealed 4 classes. Class 1 (19% of participants) assigned importance to multiple attributes particularly side effects, class 2 (34%) to physical activity limitations, class 3 (30%) to survival and physical activity limitations, and class 4 (17%) to survival. No differences in sociodemographic characteristics were observed across classes. Compared with other classes, class 4 was most likely to report having marked physical activity limitations (79%) and needing daily help (100%), while considering higher daily activity levels to be ordinary (walking >1 km [71%] or climbing several flights of stairs [50%]). Conclusion: This first patient preference study in a PAH population suggests that physical activity limitations in addition to survival matter most to patients; however, preference heterogeneity between groups of patients was observed. Patient preferences should be considered in treatment decision making to better balance patient's expectations regarding the known risk-benefit ratio of treatment.
引用
收藏
页码:206 / 215
页数:10
相关论文
共 50 条
  • [1] PATIENT PREFERENCES IN PULMONARY ARTERIAL HYPERTENSION (PAH), A LATENT CLASS ANALYSIS TO IDENTIFY PREFERENCE HETEROGENEITY
    Muehlbacher, A.
    Beaudet, A.
    Brand, M.
    DiSantostefano, R.
    Gunz, H.
    Li, W.
    Preiss, M.
    Sadler, A.
    Janssen, E.
    VALUE IN HEALTH, 2023, 26 (06) : S345 - S346
  • [2] MEASURING TREATMENT PREFERENCES FOR PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH); A DISCRETE CHOICE ANALYSIS TO IDENTIFY SCALE HETEROGENEITY
    Muehlbacher, A.
    Beaudet, A.
    Brand, M.
    DiSantostefano, R.
    Gunz, H.
    Li, W.
    Preiss, M.
    Sadler, A.
    Janssen, E.
    VALUE IN HEALTH, 2023, 26 (12) : S497 - S497
  • [3] Exploring patient preference heterogeneity for pharmacological treatments for chronic pain: A latent class analysis
    Walsh, David A.
    Boeri, Marco
    Abraham, Lucy
    Atkinson, Jo
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Hauber, Brett
    Klein, Kathleen
    Russo, Leo
    Viktrup, Lars
    Turk, Dennis
    EUROPEAN JOURNAL OF PAIN, 2022, 26 (03) : 648 - 667
  • [4] PULMONARY ARTERIAL HYPERTENSION CLINICAL PROFILES AND SURVIVAL USING LATENT CLASS ANALYSIS
    Colbert, Robert
    Huang, Shi
    Assad, Tufik
    Halliday, Stephen
    D'Amico, Reid
    West, James
    Brittain, Evan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1947 - 1947
  • [5] PATIENT PREFERENCES IN THE TREATMENT OF HEMOPHILIA: A LATENT CLASS ANALYSIS
    Muehlbacher, A.
    Sadler, A.
    Juhnke, C.
    VALUE IN HEALTH, 2019, 22 : S911 - S911
  • [6] Patient preferences in the treatment of hemophilia A: A latent class analysis
    Muehlbacher, Axel C.
    Sadler, Andrew
    Lamprecht, Bjoern
    Juhnke, Christin
    PLOS ONE, 2021, 16 (08):
  • [7] PATIENT PREFERENCES IN THE TREATMENT OF PERIODONTAL DISEASE: A LATENT CLASS ANALYSIS
    Murhlbacher, A. C.
    Juhnke, C.
    Sadler, A.
    VALUE IN HEALTH, 2018, 21 : S327 - S327
  • [8] Heterogeneity in physician and patient preferences for the treatment of renal cell carcinoma: Evidence from latent class analysis.
    Vass, Caroline
    Pinto, Cathy Anne
    Myers, Kelley
    Imai, Kentaro
    Bussberg, Cooper
    Bhattacharya, Rituparna
    Calhoun, Shawna R.
    Poulos, Christine
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [9] Using Latent Class Analysis to Model Preference Heterogeneity in Health: A Systematic Review
    Mo Zhou
    Winter Maxwell Thayer
    John F. P. Bridges
    PharmacoEconomics, 2018, 36 : 175 - 187
  • [10] Using Latent Class Analysis to Model Preference Heterogeneity in Health: A Systematic Review
    Zhou, Mo
    Thayer, Winter Maxwell
    Bridges, John F. P.
    PHARMACOECONOMICS, 2018, 36 (02) : 175 - 187